Form 4 for IMA ImageneBio, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0000899243-22-001806 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-12 | 2022-01-10+ | IMA | Zhang Xiaoyan Michelle | CSO | S - Sale+OE | $12.00 | -1,000 | 44.5K | -2% | -$12.0K |
| DM | 2022-01-12 | 2022-01-10+ | IMA | Zhang Xiaoyan Michelle | CSO | M - OptEx | $2.15 | +1,000 | 45.4K | +2% | +$2,150 |
| DM | 2022-01-12 | 2022-01-10+ | IMA | Zhang Xiaoyan Michelle | CSO | M - OptEx | $0.00 | -1,000 | 24.5K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-11 | S | D | 964 | $12.00 | 44,475 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-10 | M | A | 36 | $2.15 | 44,511 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-10 | S | D | 36 | $12.00 | 44,475 | D | — | — | |
| 4 | Common | Common Stock | 2022-01-11 | M | A | 964 | $2.15 | 45,439 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-01-10 | M | D | 36 | $0.00 | 25,437 | D | $2.15 · — to 2028-12-17 | 36 Common Stock | (F2) 25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-01-11 | M | D | 964 | $0.00 | 24,473 | D | $2.15 · — to 2028-12-17 | 964 Common Stock | (F2) 25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter. |